Benztropine, with the chemical formula 3alpha-diphenylmethoxytropane, is a tropane-based dopamine inhibitor used for the symptomatic treatment of Parkinson's disease. It is a combination molecule between a tropane ring, similar to cocaine, and a diphenyl ether from the dialkylpiperazines determined to be a dopamine uptake inhibitor since 1970. The generation...
用于治疗帕金森病。也用于药物引起的锥体外系疾患,口服1小时起效,肌肉或静脉注射数分钟内起效,作用持续24小时。具有抗胆碱及抗组胺作用,并有轻度局部麻醉作用。
Medical College of Georgia, Augusta, Georgia, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
SHANTI Clinical Trials, Colton, California, United States
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Los Angeles County Hospital, Los Angeles, California, United States
UCLA CARE Center CRS, Los Angeles, California, United States
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia, Pennsylvania, United States
Northwestern University CRS, Chicago, Illinois, United States
VA San Diego Healthcare System, San Diego, San Diego, California, United States
Washington DC VA, Washington, District of Columbia, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.